Items where Author is "Malekzadeh, R."

Article

(2024) Causes of Colectomy in Patients with Ulcerative Colitis: Findings from an Iranian National Registry. Archives of Iranian Medicine. pp. 350-356. ISSN 1029-2977

(2024) Meat consumption and incident type 2 diabetes: an individual-participant federated meta-analysis of 197 million adults with 100 000 incident cases from 31 cohorts in 20 countries. Lancet Diabetes & Endocrinology. pp. 619-630. ISSN 2213-8587

(2024) Prediction of Solar Ultraviolet Radiations Using Random Matrix Theory. Frontiers in Biomedical Technologies. pp. 6-13. ISSN 23455829 (ISSN)

(2023) Children’s and adolescents’ rising animal-source food intakes in 1990–2018 were impacted by age, region, parental education and urbanicity. Nature Food. pp. 305-319. ISSN 26621355 (ISSN)

(2023) Dietary Advanced Glycation End Products and Risk of Overall and Cause-Specific Mortality: Results from the Golestan Cohort Study. International journal of environmental research and public health. ISSN 1660-4601 (Electronic) 1661-7827 (Print) 1660-4601 (Linking)

(2023) Implementation of an In-House Platform for Rapid Screening of SARS-CoV-2 Genome Variations. Archives of Iranian Medicine. pp. 69-75. ISSN 1029-2977

(2023) Incident type 2 diabetes attributable to suboptimal diet in 184 countries. Nature Medicine. pp. 982-995. ISSN 10788956 (ISSN)

(2023) Metabolic risk factors attributed burden in Iran at national and subnational levels, 1990 to 2019. Frontiers in Public Health. ISSN 22962565 (ISSN)

(2023) Regional disparities in cancer survival in Iran: Insight from a National Surveillance of Cancer Survival in Iran (IRANCANSURV). Cancer Epidemiology. ISSN 18777821 (ISSN)

(2023) Shielding performance of multi-metal nanoparticle composites for diagnostic radiology: an MCNPX and Geant4 study. Radiological physics and technology. pp. 57-68. ISSN 1865-0341 (Electronic) 1865-0333 (Linking)

(2023) Sugar-sweetened beverage intakes among adults between 1990 and 2018 in 185 countries. Nature Communications. ISSN 20411723 (ISSN)

(2022) Comparing the risk of cardiovascular diseases and all-cause mortality in four lifestyles with a combination of high/low physical activity and healthy/unhealthy diet: a prospective cohort study. International Journal of Behavioral Nutrition and Physical Activity. p. 9.

(2022) Disease Waves of SARS-CoV-2 in Iran Closely Mirror Global Pandemic Trends. Archives of Iranian Medicine. pp. 508-522. ISSN 1029-2977

(2022) Does Opium Consumption Have Shared Impact on Atherosclerotic Cardiovascular Disease and Cancer? ARCHIVES OF IRANIAN MEDICINE. pp. 50-63. ISSN 1029-2977 1735-3947 J9 - ARCH IRAN MED

(2022) The Effectiveness of Silicone-Based Non-Lead Nanoparticles for Radiation Protection of Patients in Diagnostic Radiology by Monte Carlo Simulation. Journal of Isfahan Medical School. pp. 860-866. ISSN 10277595 (ISSN)

(2022) IRAN National Cancer Control Program (IrNCCP): Goals, Strategies, and Programs. Medical Journal of the Islamic Republic of Iran. p. 169. ISSN 1016-1430 (Print) 2251-6840 (Electronic) 1016-1430 (Linking)

(2022) National surveillance of cancer survival in Iran (IRANCANSURV): Analysis of data of 15 cancer sites from nine population-based cancer registries. International Journal of Cancer. pp. 2128-2135. ISSN 00207136 (ISSN)

(2022) Prediction of Cardiovascular Disease Mortality in a Middle Eastern Country: Performance of the Globorisk and Score Functions in Four Population-Based Cohort Studies of Iran. Int J Health Policy Manag. pp. 210-217. ISSN 2322-5939

(2022) Prediction of Cardiovascular Disease Mortality in a Middle Eastern Country: Performance of the Globorisk and Score Functions in Four Population-Based Cohort Studies of Iran. International Journal of Health Policy and Management. pp. 210-217. ISSN 23225939 (ISSN)

(2022) The burden of prostate cancer in North Africa and Middle East, 1990–2019: Findings from the global burden of disease study. Frontiers in Oncology. ISSN 2234943X (ISSN)

(2022) An office-based cardiovascular prediction model developed and validated in cohort studies of a middle-income country. JOURNAL OF CLINICAL EPIDEMIOLOGY. pp. 1-11. ISSN 0895-4356 1878-5921 J9 - J CLIN EPIDEMIOL

(2021) Cancer in Iran 2008 to 2025: Recent incidence trends and short-term predictions of the future burden. International Journal of Cancer. pp. 594-605. ISSN 00207136 (ISSN)

(2021) The Prospective Epidemiological Research Studies in IrAN (PERSIAN) Birth Cohort protocol: rationale, design and methodology. Longitudinal and Life Course Studies. pp. 241-262. ISSN 1757-9597

(2021) SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study. Lancet Infect Dis. pp. 473-481. ISSN 1473-3099 (Print) 1473-3099

(2020) COVID19 Prevention & Care; A Cancer Specific Guideline. Archives of Iranian Medicine. pp. 255-264. ISSN 1029-2977

(2020) Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019. The Lancet. pp. 1160-1203. ISSN 01406736 (ISSN)

(2020) Knowledge production in Iranian cardiovascular research centers: A way to reduce the burden of disease. ARYA Atherosclerosis. pp. 72-78. ISSN 1735-3955

(2020) Prediction of Cardiovascular Disease Mortality in a Middle Eastern Country: Performance of the Globorisk and Score Functions in Four Population-Based Cohort Studies of Iran. Int J Health Policy Manag. ISSN 2322-5939

(2020) SD1000: High Sustained Viral Response Rate in 1361 Patients With Hepatitis C Genotypes 1, 2, 3, and 4 Using a Low-cost, Fixed-dose Combination Tablet of Generic Sofosbuvir and Daclatasvir: A Multicenter, Phase III Clinical Trial. Clinical Infectious Diseases. pp. 2206-2212. ISSN 1058-4838

(2020) Subcutaneous tocilizumab in adults with severe and critical COVID-19: A prospective open-label uncontrolled multicenter trial. International Immunopharmacology. ISSN 1567-5769

(2020) The combination of sofosbuvir and daclatasvir is effective and safe in treating patients with hepatitis C and severe renal impairment. Journal of Gastroenterology and Hepatology. pp. 1590-1594. ISSN 0815-9319

(2019) Cancer incidence in Iran in 2014: Results of the Iranian National Population-based Cancer Registry. Cancer Epidemiology. pp. 50-58. ISSN 18777821 (ISSN)

(2019) Effectiveness of polypill for primary and secondary prevention of cardiovascular diseases (PolyIran): a pragmatic, cluster-randomised trial. Lancet. pp. 672-683. ISSN 0140-6736

(2019) Iran in transition. Lancet. pp. 1984-2005. ISSN 0140-6736

(2019) Iranian Registry of Crohn's and Colitis (IRCC): first nation-wide IBD registry in Middle East, a study protocol. Journal of Crohns & Colitis. S492-S493. ISSN 1873-9946

(2019) Iranian Registry of Crohn's and Colitis: study profile of first nation-wide inflammatory bowel disease registry in Middle East. Intest Res. ISSN 1598-9100 (Print) 1598-9100 (Linking)

(2019) The combination of sofosbuvir and daclatasvir is well tolerated and extremely effective in treating patients with hepatitis C with severe renal impairment including hemodialysis patinets. Journal of Hepatology. E233-E233. ISSN 0168-8278

(2018) Cardiovascular mortality in a Western Asian country: results from the Iran Cohort Consortium. Bmj Open. ISSN 2044-6055

(2018) Contributions of mean and shape of blood pressure distribution to worldwide trends and variations in raised blood pressure: A pooled analysis of 1018 population-based measurement studies with 88.6 million participants. International Journal of Epidemiology. 872-883i. ISSN 03005771 (ISSN)

(2018) Liver Transplantation Status in Iran: A Multi-center Report on the Main Transplant Indicators and Survival Rates. Archives of Iranian Medicine. pp. 275-282. ISSN 1029-2977

(2018) Molecular evolution and phylodynamics of hepatitis B virus infection circulating in Iran. Archives of Virology. pp. 1479-1488. ISSN 0304-8608

(2018) Prospective Epidemiological Research Studies in Iran (the PERSIAN Cohort Study): Rationale, Objectives, and Design. AMERICAN JOURNAL OF EPIDEMIOLOGY. pp. 647-655. ISSN 00029262 (ISSN)

(2018) SD1000: 96.4 SVR12 in 1237 patients with hepatitis C genotypes 1, 2, 3, 4 using co-formulated sofosbuvir/daclatasvir tablets manufactured in Iran - a multicenter phase 3 clinical trial including HIV co-infected, transplant, and hemodialysis patients. Journal of Viral Hepatitis. pp. 198-199. ISSN 1352-0504

(2016) The Combined Effects of Healthy Lifestyle Behaviors on All-Cause Mortality: The Golestan Cohort Study. Archives of Iranian Medicine. pp. 752-761. ISSN 1029-2977

(2016) Emerging Epidemic of Inflammatory Bowel Disease in a Middle Income Country: A Nation-wide Study from Iran. Archives of Iranian Medicine. pp. 2-15. ISSN 1029-2977

(2016) Recommendations for the Clinical Management of Hepatitis C in Iran: A Consensus-Based National Guideline. Hepatitis Monthly. ISSN 1735-143X

(2015) Evolution of hepatitis B virus surface gene and protein among Iranian chronic carriers from different provinces. Iranian journal of microbiology. pp. 214-20. ISSN 2008-3289 (Print) 2008-3289 (Linking)

(2015) Polypill for the prevention of cardiovascular disease (PolyIran): study design and rationale for a pragmatic cluster randomized controlled trial. European Journal of Preventive Cardiology. pp. 1609-1617. ISSN 2047-4873